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Mesenchymal stem cells suppress neuronal
apoptosis and decrease IL-10 release via
the TLR2/NFκB pathway in rats with
hypoxic-ischemic brain damage
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Abstract
Background: Hypoxic–ischemic brain damage (HIBD) is a major cause of infant mortality and neurological disability
in children. Many studies have demonstrated that mesenchymal stem cell (MSC) transplantation facilitates the
restoration of the biological function of injured tissue following HIBD via immunomodulation. This study aimed
to elucidate the mechanisms by which MSCs mediate immunomodulation via the key effectors Toll-like receptor
2 (TLR2) and interleukin-10 (IL-10).
Results: We showed that TLR2 expression in the brain of HIBD rats was upregulated following HIBD and that MSC
transplantation suppressed the expression of TLR2 and the release of IL-10, thereby alleviating the learning-memory
deficits of HIBD rats. Following treatment with the specific TLR2 agonist Pam3CSK4 to activate TLR2, learning-memory
function became further impaired, and the levels of nuclear factor kappa B (NFκB) and Bax expression and IL-10 release
were significantly increased compared with those in HIBD rats that did not receive Pam3CSK4. In vitro, we found that
MSC co-culture downregulated TLR2/NFκB signaling and repressed Bax expression and IL-10 secretion in oxygen and
glucose deprivation (OGD)-injured adrenal pheochromocytoma (PC12) cells. Furthermore, NFκB and Bax expression
and IL-10 release were enhanced following Pam3CSK4 treatment and were decreased following siTLR2 treatment in
OGD-injured PC12 cells in the presence or absence of MSCs.
Conclusions: Our data indicate that TLR2 is involved in HIBD and that MSCs decrease apoptosis and improve
learning-memory function in HIBD rats by suppressing the TLR2/NFκB signaling pathway via a feedback mechanism
that reduces IL-10 release. These findings strongly suggest that MSC transplantation improves HIBD via the inhibition of
the TLR2/NFκB pathway.
Keywords: Mesenchymal stem cells, Hypoxic–ischemic brain damage, Oxygen and glucose deprivation, Toll-like
receptor 2, Nuclear factor kappa B, Interleukin-1
Background
Perinatal hypoxic-ischemic brain damage (HIBD) is a major
cause of neonatal death that occurs in three to five out of
every 1000 live births [1]. As many as 10 to 60 % of infants
who experience HIBD die during the newborn period, and
up to 25 % of the survivors of such injury exhibit a variety
of serious neurological sequelae that decrease the quality of
life of HIBD children and increase the economic and social
burdens on their families [2, 3]. Because the pathogenesis
of HIBD involves a series of complex processes [4, 5], it is
unreasonable to expect any single intervention to provide a
uniformly favorable outcome. Therefore, current thera-
peutic strategies typically focus on arresting the progression
of one or more detrimental processes.
Based on developments from mesenchymal stem cell
(MSC) studies, cell therapy has become a research focus
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for HIBD. Studies from several laboratories, including
our own, have indicated that MSC treatment of ischemic
brain injury provides beneficial effects [6–10]. In previ-
ous years, studies of MSC therapy for HIBD have fo-
cused on the multipotent differentiation properties of
MSCs, with the aim of replacing the lost neurons and
glial cells [11, 12]. However, administered MSCs cannot
survive for long in the brains of recipients [13]; thus, in-
creasing attention is being paid to their immunomodula-
tory functions in the injury microenvironment [14–16].
Toll-like receptors (TLRs) are transmembrane pattern
recognition receptors (PRRs) [17] that form a family of in-
nate immune system receptors that respond to pathogen-
derived and tissue damage-related ligands [18]. TLR2 is a
TLR family member that is known to play an important
role in ischemic brain damage [19]. However, few studies
have been performed to determine whether MSC trans-
plantation regulates the TLR2 signaling pathway, thereby
improving learning-memory function following HIBD.
The aims of the present study were to elucidate whether
changes in the TLR2 expression level are associated with
learning-memory function following HIBD and whether
MSC transplantation regulates the TLR2 signaling path-
way and promotes recovery from HIBD. First, we trans-
planted MSCs into HIBD rats and measured the changes
in the TLR2 expression levels in the hippocampus. Next,
we verified that TLR2 is an important factor in learning-
memory function following HIBD using Pam3CSK4,
which is a specific agonist of TLR2. Second, an oxygen-
glucose deprivation (OGD) model was performed on ad-
renal pheochromocytoma (PC12) cells in vitro to simulate
neuronal injury in HIBD rats in vivo to further confirm
that TLR2 participates in MSC-mediated immunomo-
dulation. Finally, we treated a co-culture system with
Pam3CSK4 and siTLR2 to identify the mechanism
underlying MSC-mediated neuroprotection via TLR2
signaling. Furthermore, we monitored the changes in
the release of the cytokine interleukin (IL)-10 both in
vivo and in vitro. This study might provide a new per-
spective revealing the immunomodulatory and neuro-
protective properties of MSC therapy.
Results
MSC transplantation decreased the TLR2 expression, thus
improving the learning-memory function of neonatal rats
following HIBD
In the Morris water maze test, the escape latency and the
path length required to locate the platform were recorded
to assess the learning-memory function of the rats. As
shown in Fig. 1b-c, all three groups exhibited similar es-
cape latencies and path lengths during the visual training
on the first day (1 d), suggesting that neither HIBD nor
MSC transplantation impaired rat motility or vision. In the
directional navigation experiment, the escape latencies of
all groups were gradually reduced from 2 d to 5 d (Fig. 1d).
However, the HIBD rats- exhibited longer escape latencies
than the control rats, and the escape latency of the MSCs
group- was significantly shorter than that of the HIBD
group-, although the escape latency of the MSCs group did
not reach the level of the control group. On the final test
day, the average time that the HIBD group remained in the
formerly platform-containing quadrant was the shortest
among the three groups. Compared with the HIBD group,
the MSCs group displayed an increased duration in this
quadrant, although this difference was not significant
(Fig. 1e). These results suggested that MSC transplantation
partially restores the learning-memory function of neonatal
HIBD rats.
Furthermore, the TLR2 mRNA levels in the brains of
the HIBD rats gradually increased, and these levels
were significantly different between the HIBD and con-
trol groups at both 7 d and 14 d after injury. Interest-
ingly, the TLR2 mRNA level was significantly decreased
in the MSCs group compared with the HIBD group at
14 d after injury (Fig. 1f ). Western blot analysis showed
the same trends for TLR2 protein expression (Fig. 1g-
h). Moreover, the levels of secreted IL-10 in the brains
of the HIBD group were increased at 3 d and 14 d after
HIBD (Fig. 1i) and were significantly higher than those
of the control group. After MSC transplantation, the
IL-10 concentration in the rat brain was significantly
lower than that for HIBD alone at both 3 d and 14 d
after injury. These results indicated that TLR2 and IL-
10 might be involved in the post-HIBD recovery
process after MSC transplantation.
TLR2 activation decreased the learning-memory function
of neonatal HIBD rats
To evaluate the effects of TLR2 on the brains of HIBD
rats, Pam3CSK4, a TLR2-specific agonist, was adminis-
tered to neonatal HIBD rats. The results of the Morris
water maze test at 1 d revealed equivalent values for
both the escape latency and the path length between the
HIBD and Pam3 groups (Fig. 2b-c), demonstrating that
Pam3CSK4 had no effect on the motility or vision of the
neonatal rats. However, the escape latency was extended
in the rats that were treated with Pam3CSK4 throughout
the 2 d to 5 d period of the directional navigation ex-
periment (Fig. 2d), and the average duration spent in the
former platform quadrant on the final day of the Morris
water maze test tended to be lower in the Pam3CSK4
group compared with the HIBD group (Fig. 2e).
After Pam3CSK4 treatment, the levels of TLR2 mRNA
and protein expression were significantly increased in the
injured brain tissue, clearly indicating that Pam3CSK4 en-
hanced TLR2 expression in vivo. As shown in Fig. 2f-h,
Pam3CSK4 also markedly upregulated the mRNA and
protein expression of NFκB P65 and the apoptotic factor
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Fig. 1 MSC transplantation improved the learning-memory function and reduced the TLR2/IL-10 expression levels of HIBD rats. a Diagram illustrating the
experimental protocols of the treatments and tests used in the rats. b-c The escape latencies and path lengths to reach the visible platform on the first
day of the Morris water maze test for the control, HIBD and MSCs rats. d From the 2nd to the 5th day of the Morris water maze test, the escape latencies
to locate the visible platform gradually decreased in all three groups. e The duration spent in the former platform quadrant by each of the three groups
on the final day of the Morris water maze test. n = 20 in each group. f-g The TLR2 mRNA and protein expression levels in the rat brains on the 3rd, 7th
and 14th days following HIBD. n = 5 in each group. h The quantifications of WB signal in g. i The changes in the IL-10 secretion levels in the brains at the
three time points after HIBD in all three groups. n = 6 in each group. #P< 0.05 vs. the control group; &P< 0.05 vs. the HIBD group
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Fig. 2 (See legend on next page.)
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Bax compared with that for HIBD alone. Interestingly, the
IL-10 concentration in the brains of the HIBD rats was
significantly higher in the Pam3CSK4 group than in the
HIBD group (Fig. 2i). The above results further indicated
that the levels of TLR2 expression and IL-10 secretion are
closely associated with the severity of injury by affecting
apoptosis in HIBD rats.
MSC transplantation reduced TLR2 expression and
decreased apoptosis in the brains of HIBD rats
To evaluate the localization of TLR2 expression in the
brains of HIBD rats, we used double-staining immuno-
fluorescence to examine the cerebral cortex of three
groups of rats: control, HIBD and MSCs. As shown in
Fig. 3a, TLR2 was co-expressed with NSE (Fig. 3a-a, a-d
and a-g) but not with GFAP (Fig. 3a-b, a-e and a-h) or
Iba1 (Fig. 3a-c, a-f and a-i), suggesting that TLR2 is mainly
expressed in the neuron. Meanwhile, we also observed
higher TLR2 expression after HIBD (Fig. 3a-d, a-e and a-
f), and MSC transplantation dramatically reduced the ex-
pression level of TLR2 (Fig. 3a-g, a-h and a-i); this result
was consistent with the changes in TLR2 protein expres-
sion that were observed by Western blotting.
To further verify the effects of MSC transplantation on
anti-apoptosis, TUNEL staining was performed in the
brains of HIBD rats. As shown in Fig. 3b and c, the
amount of TUNEL-positive cells was significantly greater
in the HIBD group than in the control group, while the
number of apoptotic cells was dramatically decreased fol-
lowing MSC transplantation-, suggesting that MSC trans-
plantation suppressed apoptosis following HIBD.
Co-culturing OGD-injured PC12 cells with MSCs decreased
TLR2 expression and suppressed apoptosis
To further elucidate the effects of TLR2 and IL-10 on neo-
natal HIBD rats, an in vitro OGD model was applied to
PC12 cells to simulate HIBD. As shown in Fig. 4a-c, in
OGD-injured PC12 cells, the TLR2 mRNA and protein
expression levels were increased, and these levels were sig-
nificantly decreased when the PC12 cells were co-cultured
with MSCs. These findings were very consistent with the
changes observed in the rat brains 14 d after HIBD. Al-
though there was no significant difference in the NFκB
P65 mRNA expression level among the control, OGD and
OGD+MSCs groups (Fig. 4d), the NFκB P65 protein
expression level was clearly increased in the OGD group
and reduced in the OGD+MSCs group (Fig. 4e-f). Both
the mRNA and protein expression levels of Bax were also
significantly increased after OGD treatment and were sig-
nificantly decreased by MSC co-culture (Fig. 4g-i). In
addition, as shown in Fig. 5a, the numbers of both
annexin V-positive and PI-positive cells were significantly
higher in PC12 cells injured by OGD compared with those
of the uninjured group (Fig. 5a a-f, b-c). These values were
obviously decreased in OGD PC12 cells after MSC co-
culture (Fig. 5a g-i, b-c). These results indicated that the
separate co-culture with MSCs protected OGD-injured
PC12 cells from apoptosis via the TLR2/NFκB pathway.
Furthermore, the level of IL-10 secreted from PC12 cells
following OGD exposure was significantly increased by
more than 3-fold compared with that of non-OGD-
exposed cells. In OGD-injured PC12 cells co-cultured
with MSCs, the release of IL-10 was clearly alleviated
compared with that in non-cultured OGD-injured PC12
cells, but a significant difference between the control and
OGD+MSCs groups remained (Fig. 4j). These results fur-
ther demonstrated that IL-10 might be involved in the
regulation of TLR2 following neuronal damage.
TLR2 pathway in PC12 cells after Pam3CSK4 or Ad-siTLR2
treatment
To confirm the regulatory role of TLR2 in neuronal in-
jury, Pam3CSK4 or siTLR2 was applied to PC12 cells.
As shown in Fig. 6a-c, Pam3CSK4 significantly upregu-
lated TLR2 mRNA and protein expression in PC12 cells
compared with that in non-Pam3CSK4–treated control
cells-, whereas Ad-siTLR2 treatment significantly down-
regulated the TLR2 expression levels in PC12 cells
compared with those of Ad-RFP treatment group. Add-
itionally, we measured the expression levels of NFκB in
PC12 cells after Pam3CSK4 or Ad-siTLR2 treatment. As
shown in Fig. 6d-f, the changes in the mRNA and pro-
tein expression levels of NFκB completely mirrored
those of TLR2 following Pam3CSK4 or Ad-siTLR2 treat-
ment. The above results revealed that Pam3CSK4 or Ad-
siTLR2 treatment not only specifically activated and
inhibited TLR2 expression, respectively, but also effect-
ively induced and impaired the TLR2 signaling pathway,
respectively, in PC12 cells.
(See figure on previous page.)
Fig. 2 Pam3CSK4 exacerbated learning-memory dysfunction and stimulated the TLR2/NFκB signaling pathway and IL-10 secretion in HIBD rats.
a Diagram illustrating the experimental protocols of treatments and tests used in the rats. b-c The escape latencies and path lengths to reach
the visible platform on the first day of the Morris water maze test for the HIBD and Pam3CSK4 groups. d The escape latencies to reach the visible platform
on the 2nd through the 5th days of the Morris water maze test for the Pam3CSK4-treated and HIBD groups. e The duration spent in the hidden platform
quadrant by the Pam3CSK4-treated and HIBD groups. n = 20 in each group. f-g The Pam3CSK4-induced mRNA and protein expression levels of TLR2, NFκB
P65 and Bax in the brains of 4-week-old rats. n = 5 in each group. h The quantifications of WB signal in G. i IL-10 release in the brains of 4-week-old rats in
HIBD and Pam3CSK4 groups. n = 6 in each group. #P< 0.05 vs. the HIBD group
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Fig. 3 MSC transplantation decreased the expression of TLR2 in neurons and suppressed apoptosis in the cerebral cortex of HIBD rats. a Double
immunofluorescence staining of NSE or GFAP or Iba1 (green) together with TLR2 nred) in the cerebral cortex of rats of the control, HIBD and MSCs
groups. a, d and g. Double immunofluorescence staining of NSE together with TLR2. The white arrows indicate co-localization of NSE and TLR2. b, e
and h. Double immunofluorescence staining of GFAP together with TLR2. c, f and i. Double immunofluorescence staining of Iba1 together with TLR2.
Scale bar = 50 μm. n = 4 in each group. b TUNEL staining in the rat cerebral cortex of the control, HIBD and MSCs groups. a, d and g. TUNEL-positive
cells. b, e and h. DAPI-stained cells. c, f and i. Merged images of TUNEL-positive cells and DAPI-stained cells. The white arrows indicate TUNEL-positive
cells that were merged with DAPI-stained cells. Scale bar = 50 μm. c The percentage of TUNEL-positive cells in the three groups of control, HIBD and
MSCs. n = 5 in each group. The results are presented as the mean ± SEM. #P < 0.05 vs. the control group; &P < 0.05 vs. the HIBD group
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Fig. 4 Co-culturing OGD-injured PC12 cells with MSCs decreased the expression of TLR2, NFκB, Bax and IL-10. a-b The mRNA and protein expression
levels of TLR2 in OGD-injured PC12 cells in the presence or absence of MSCs. n = 6 in each group. c The quantifications of WB signal in b. d-e The mRNA
and protein expression levels of NFκB P65 in OGD-injured PC12 cells in the presence or absence of MSCs. n = 6 in each group. f The quantifications of
WB signal in e. g-h The mRNA and protein expression levels of Bax in OGD-injured PC12 cells in the presence or absence of MSCs. n = 6 in each group.
i The quantifications of WB signal in h. j The concentrations of IL-10 released into the culture media were measured in the control, OGD and
OGD +MSCs groups via ELISA. n = 6 in each group. #P < 0.05 vs. the control PC12 cells; &P < 0.05 vs. the OGD-injured PC12 cells
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MSCs protected against TLR2 signaling pathway-mediated
apoptosis in PC12 cells subjected to OGD injury
To investigate whether the TLR2 pathway is critically in-
volved in the enhanced recovery from OGD exposure
that is mediated by MSCs, Pam3CSK4 or Ad-siTLR2
treatment was applied to the in vitro co-culture model
of MSCs and OGD-injured PC12 cells. As shown in
Fig. 7b-d, TLR2 mRNA and protein expression levels
were increased by Pam3CSK4 treatment and reduced by
Ad-siTLR2 treatment in OGD-injured PC12 cells in the
presence or absence of MSCs. However, compared with
the situation for OGD injury in the absence of MSCs, the
TLR2 expression levels in PC12 cells were significantly de-
creased following OGD in the presence of MSCs when
treated with either Pam3CSK4 or Ad-siTLR2-. Moreover,
the changes in NFκB expression were similar to those of
TLR2 in all groups regardless of the presence of MSCs
(Fig. 7e-g). These results suggested that co-culturing the
PC12 cells with MSCs could modulate the TLR2 signaling
pathway via NFκB, thereby alleviating OGD-mediated
damage to PC12 cells.
Intriguingly, consistent with the increase in TLR2 ex-
pression, the Bax mRNA and protein expression levels
were increased by the application of Pam3CSK4 to OGD-
injured PC12 cells. In contrast, the Bax expression levels
were reduced by Ad-siTLR2 treatment (Fig. 7h-j). Co-
culturing PC12 cells with MSCs dramatically suppressed
the Bax expression levels in OGD-injured PC12 cells com-
pared with those in monocultured OGD injured-PC12
cells in the presence of either Pam3CSK4 or Ad-siTLR2-.
These findings revealed that co-culturing these cells with
MSCs might reduce apoptosis in injured cells via TLR2.
Surprisingly, we found that the changes in the IL-10
concentrations were highly consistent with the changes
in the TLR2 and Bax expression levels. As shown in
Fig. 7k, Pam3CSK4 treatment enhanced the IL-10 re-
lease from OGD-injured PC12 cells, whereas Ad-siTLR2
infection reduced the IL-10 release. However, in MSC
co-cultures, the IL-10 concentrations were significantly
suppressed in OGD-injured PC12 cells that were treated
with either Pam3CSK4 or Ad-siTLR2-. These findings
indicated that TLR2 might directly or indirectly regulate
the secretion of IL-10 into the microenvironment sur-
rounding injured PC12 cells and that co-culturing these
cells with MSCs decreases the release of IL-10 by modu-
lating the TLR2 pathway.
Fig. 5 MSC co-culture suppressed apoptosis in OGD-injured PC12 cells. a Annexin V-FITC/PI double staining of PC12 cells in the control, OGD
and OGD +MSCs groups. a, d and g. Annexin-V-positive PC12 cells in the control, OGD and OGD + MSCs groups. b, e and h. PI-positive PC12
cells in the control, OGD and OGD + MSCs groups. c, f and i. Annexin-V-positive cells and PI-positive cells merged with bright-field images of
PC12 cells in the control, OGD and OGD + MSCs groups. Scale bar = 100 μm. b-c Annexin-V and PI sum intensity of PC12 cells in the control,
OGD and OGD + MSCs groups. n = 5 in each group. The results are presented as the mean ± SEM. #P < 0.05 vs. control PC12 cells; &P < 0.05 vs.
OGD-injured PC12 cells
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Discussion
In the present study, we sought to clarify whether MSC
transplantation modulates TLR2 signaling and improves
the recovery of learning-memory function following HIBD
and the possible mechanism(s) underlying these effects.
The primary findings of this study were that MSC treat-
ment ameliorated the deficits in learning-memory function
and decreased the TLR2 expression levels in the brain of
HIBD rats via suppression of the TLR2–dependent NFκB
signaling pathway to decrease apoptosis and IL-10 release.
Substantial evidence indicates that MSC treatment
improves behavioral outcomes following HIBD [6–10,
20–22]. The present study also demonstrated that MSC
transplantation effectively alleviated the impairment of
the learning-memory function of neonatal HIBD rats.
Concurrently, we found that MSCs suppressed the
hypoxia-ischemia–induced TLR2 expression in the
brains of HIBD rats. These results indicated that TLR2
might be involved in the recovery of learning-memory
function after MSC transplantation into HIBD rats. To
date, several studies have demonstrated that MSCs alleviate
neuronal dysfunction via the differentiation of MSCs into
neurons at the lesion site [11, 12] because only a very small
percentage of MSCs differentiate into a parenchymal cell
phenotype [23]. Therefore, increasing numbers of investi-
gators have shifted their focus to the immunomodulatory
functions of MSCs that stimulate the release of trophic fac-
tors in the injury microenvironment [7]. Previous studies
have demonstrated that MSC treatment represses inflam-
mation and facilitates the development and integration of
new neurons by decreasing the levels of pro-inflammatory
cytokines, which are secreted from activated microglia in
the ischemic brain [9, 24]. Nevertheless, none of these
studies has demonstrated the effects of MSC transplant-
ation on TLR2 signaling in the HIBD brain.
TLRs are a family of innate immune system receptors
that respond to diverse pathogen-derived and injury-
induced endogenous ligands [17]. TLR2 is upregulated
and activated in neurons in response to ischemia, and
focal cerebral ischemic injury is alleviated in TLR2-
deficient mice [25, 26]. To confirm the effect of TLR2 on
learning-memory function, neonatal rats were injected
with Pam3CSK4 prior to HIBD. The results indicated that
the activation of the TLR2/NFκB signaling pathway exac-
erbates the effects of HIBD, including apoptosis. These
findings are consistent with those of an in vitro study of
the amyloid β peptide-induced inflammatory response in
mouse NG108-15 neural cells [27]. Some studies have
found that heat shock proteins (HSPs) in damaged tissue
activate the TLR2-dependent NFκB signaling pathway to
promote the expression of the cytokines tumor necrosis
factor-α (TNFα), IL-1β and IL-6 [28], which participate in
Fig. 6 Pam3CSK4 effectively activated and Ad-siTLR2 specifically blocked the TLR2/NFκB signaling pathway in PC12 cells. a-b The mRNA and protein
expression levels of TLR2 in PC12 cells following Pam3CSK4 treatment or Ad-siTLR2 infection. c The quantifications of WB signal in b. n = 6 in each
group. d-e The mRNA and protein expression levels of NFκB in PC12 cells following Pam3CSK4 treatment or Ad-siTLR2 infection. f The quantifications
of WB signal in e. n = 6 in each group. #P < 0.05 vs. untreated PC12 cells; &P < 0.05 vs. Ad-RFP-infected PC12 cells
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inflammatory injury to induce neuronal apoptosis. A study
by Kim also demonstrated that HSP60 increases the TLR2
expression level and induces TLR-dependent apoptosis via
activation of the NFκB pathway [29]. Therefore, we hy-
pothesized that MSC transplantation might alleviate the
apoptosis induced by HIBD via the suppression of the
TLR2/NFκB signaling pathway.
The PC12 cell line has been widely used as an in vitro
model to examine neurological diseases [30–32]. To
confirm that MSCs suppress the TLR2 signaling pathway
Fig. 7 MSCs modulated the TLR2/NFκB signaling pathway and suppressed the apoptosis of OGD-injured PC12 cells and the secretion of IL-10.
a Diagram illustrating the experimental protocols of the treatments and tests for PC12 cells. b-c The TLR2 mRNA and protein expression levels
in co-cultures of MSCs with OGD-injured PC12 cells that received Pam3CSK4 or Ad-siTLR2 treatment. n = 6 in each group. d The quantifications
of WB signal in c. e-f The mRNA and protein expression levels of NFκB P65 in co-cultures of MSCs with OGD-injured PC12 cells that were
treated with Pam3CSK4 or Ad-siTLR2. n = 6 in each group. g The quantifications of WB signal in f. h-i The changes in the mRNA and protein
expression levels of Bax in co-cultures of MSCs with OGD-injured PC12 cells that were treated with Pam3CSK4 or Ad-siTLR2. n = 6 in each
group. j The quantifications of WB signal in i. k The changes in IL-10 release in co-cultures of MSCs with OGD-injured PC12 cells that received
Pam3CSK4 or Ad-siTLR2 treatment. n = 6 in each group. #P < 0.05 vs. OGD-injured PC12 cells that were treated with Pam3CSK4 or Ad-siTLR2
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and inhibit apoptosis following HIBD, we utilized an in
vitro OGD model in PC12 cells. The data demonstrated
that co-culturing PC12 cells with MSCs repressed the
activation of TLR2/NFκB signaling, thereby decreasing
apoptosis in the OGD-injured PC12 cells; this finding in-
dicated that MSCs might play a protective role via the
immunosuppression of the TLR2/NFκB signaling path-
way to reduce OGD-induced apoptosis. These results
are consistent with our findings in a previous study
showing that apoptosis is suppressed in MSC co-culture
via the modulation of the microenvironment surround-
ing the injured neurons [33]. However, it should be
noted that this study only demonstrated that MSC trans-
plantation modulates the TLR2/NFκB signaling pathway
during HIBD injury. Further studies should focus on the
mechanism underlying the MSC-mediated immunomo-
dulation of TLR2.
IL-10 limits the production of pro-inflammatory cyto-
kines and chemokines [34]. More severe damage and even
death can occur in acutely infected hosts if IL-10 signaling
is blocked [35]. In the current study, we were surprised to
find that the pattern of changes in the IL-10 secretion
levels was highly consistent with the alterations in TLR2
expression both in vivo and in vitro. Our results revealed
that IL-10 levels were significantly increased in both HIBD
rats and OGD-injured PC12 cells and were significantly al-
leviated by MSC transplantation or co-culture, respectively.
Moreover, Pam3CSK4 treatment enhanced IL-10 release
both in vivo and in vitro, whereas Ad-siTLR2 infection
suppressed IL-10 secretion. These changes in IL-10 release
suggested that the MSC transplantation-mediated ef-
fect on IL-10 secretion is regulated by TLR2/NFκB sig-
naling in HIBD rats. Yang et al. found that adult neural
stem cells (aNSCs) that were engineered to express IL-
10 were better able to induce immunosuppression,
remyelination and neuronal repair [21]. Based on the
combination of our discoveries regarding the neuro-
protective effect of MSCs and the results of their
study, we speculate that MSCs suppress apoptosis and
alleviate HIBD injury by decreasing the levels of pro-
inflammatory cytokines in the injury microenviron-
ment, which provides feedback that reduces IL-10
secretion. Currently, we are investigating the effects of
IL-10 during MSC transplantation therapy on HIBD
using siRNA targeting IL-10.
Conclusions
Our results demonstrated that TLR2 is upregulated fol-
lowing HIBD and that MSC transplantation enhances
the recovery of learning-memory function in HIBD rats
and plays a neuroprotective role by reducing the apop-
tosis of damaged nerve cells via the suppression of the
TLR2/NFκB signaling pathway. Additionally, we revealed
that the cytokine IL-10 is involved in HIBD and is
regulated by the TLR2/NFκB pathway following the ad-
ministration of MSCs. These findings might provide new
evidence supporting the use of MSC therapies for HIBD.
Materials and methods
Animal groups
All animal experimental protocols were approved by the
Animal Experimentation Ethical Committee of the Zoology
Center at Chongqing Medical University (Chongqing,
China). Specific pathogen-free (SPF)-grade Wistar rats
(6 weeks old) were purchased from the Experimental Ani-
mal Centre of Daping Hospital at the Third Military Med-
ical University (Chongqing, China), and the SPF-grade
animal housing was certified for experimental animals
(SYXK(Yu)2012-0015). Seven-day postnatal rats were used
to establish the HIBD model as reported previously [36,
37]. Briefly, left carotid artery ligation was carried out in 7-
day-postnatal rats. Two hours later, the pups were exposed
to 8 % oxygen at 37 °C for 2.5 h and then they were
returned to their dams.
All pups were randomly separated into one of the follow-
ing four groups: control, HIBD, MSCs, and Pam3CSK4.
The rats in the control group were only subjected to a cer-
vical skin incision that was subsequently sutured. The
HIBD pups in the MSCs group were transfused with 1.5 ×
106 MSCs in 5 μL of phosphate-buffered saline (PBS)
(Hyclone, USA) via intracerebroventricular injections 2 days
after hypoxia-ischemia [37]. The rat primary MSCs that
were used were isolated and expanded as described
previously [38]. Briefly, the primary MSCs were iso-
lated from the bone marrow in leg bones of 3 to 4-
week-old rats. The cells were cultured with DMEM/
F12 supplemented with 10 % fetal bovine serum (FBS).
The medium was replaced with fresh medium every 2-
3 days. The pups in the Pam3CSK4 group were
infused with 30 μg of Pam3CSK4 16 h before hypoxic-
ischemic injury.
Morris water maze test
Four weeks after the treatments, 15 rats per group
were subjected to the Morris water maze task (MWM
SLY-WMS 2.0, China) to evaluate their spatial learning
and memory functions as reported previously [39].
The OGD cell model and the co-culture systems
PC12 cells were purchased from the Cell Bank of the
Shanghai Institute of Cell Biology at the Chinese Academy
of Sciences (Shanghai, China). The cells were cultured as
described previously [33]. At approximately 90 % conflu-
ence, the PC12 cell culture medium was replaced with
Earle’s balanced salt solution (EBSS) (Hyclone, USA).
Then, the cells were placed in an incubator (Thermo
Forma 3111, Thermo Scientific) containing 5 % O2 and
Gu et al. Molecular Brain  (2015) 8:65 Page 11 of 14
95 % N2 at 37 °C for 6 h. Normal PC12 cells that were not
subjected to OGD served as controls. A total of 2 × 106
MSCs were added to Dulbecco’s modified Eagle’s medium
(DMEM) (Hyclone, USA) to generate co-cultures with the
OGD-injured PC12 cells, and the cells treated in this
manner were referred to as the OGD+MSCs group.
PC12 cell treatments
For Pam3CSK4 treatment, normal PC12 cells were
treated with 300 ng/ml Pam3CSK4 (InvivoGen at the
time of OGD injury, and cells treated with an equal vol-
ume of PBS served as the controls. For the Ad-siTLR2
group, normal PC12 cells at 80 % confluence were in-
fected with siTLR2 adenovirus [40] for 24-48 h, and
PC12 cells subjected to an equivalent infection load of
RFP-expressing adenovirus served as the controls.
For the three OGD groups that were subjected to dif-
ferent treatments, the PC12 cells were subjected to
OGD for 6 h after Pam3CSK4 treatment or after siTLR2
infection for 24 h. Untreated PC12 cells that were sub-
jected to OGD were used as negative controls. The
PC12 cells that were treated with Pam3CSK4 or siTLR2
were co-cultured with MSCs for an additional 24 h fol-
lowing OGD. Untreated cells were exposed to OGD and
co-cultured with MSCs for use as negative controls for
the other MSC co-culture groups.
RNA extraction and real-time PCR
The sample preparation and PCR reaction protocols
were identical to those of a previous report [33]. The rat
TLR2, NFкB P65, Bax and glyceraldehyde 3-phosphate
dehydrogenase (GAPDH) primer sequences were de-
signed using Primer 5 software and are listed in Table 1.
The Ct values derived from the real-time PCR data were
utilized to ensure that an individual PCR product was
amplified in each reaction. All samples were normalized
to the endogenous levels of GAPDH.
Western blot
Total protein was extracted using a specific extraction kit
(Bioteke Co., Ltd.). Approximately 50 μg of total protein
per well was loaded on a 10 % sodium dodecyl sulfate
(SDS)-polyacrylamide gel (Beyotime). The protein isola-
tion procedure corresponded to the conventional method
used for Western blot. The anti-TLR2 (1:1000, Abcam,
ab13855), anti-NFкB P65 (1:500, Santa Cruz, sc-8008),
anti-Bax (1:500, Santa Cruz, sc-7480) and anti-β-actin pri-
mary antibodies (1:500, Santa Cruz, sc-130065) were incu-
bated at 4 °C overnight. The next day, the membranes
were probed with horseradish peroxidase (HRP)-conju-
gated secondary antibodies (1:5000, Santa Cruz) at room
temperature for 1 h, and the chemiluminescence of the
protein bands was measured using a Syngene GBox Im-
aging System.
Enzyme-linked immunosorbent assay (ELISA)
The levels of IL-10 cytokine release in the brain tissues
and the culture media from the various treatment
groups were measured using an ELISA kit (Raybiotech,
Inc., Norcross, GA, USA). The colorimetric absorbance
was recorded at a wavelength of 450 nm. The IL-10
concentrations were calculated according to a standard
curve constructed for each assay, and each assay was
performed in triplicate.
TUNEL assay and immunofluorescence staining
TUNEL assay and immunofluorescence double-labeling
staining of TLR2 with NSE, GFAP or Iba1 were per-
formed on the brains of rats in the control, HIBD and
MSCs groups. Briefly, all rats were anesthetized and
transcardially perfused with 4 % paraformaldehyde
(Kelong Chemical Co. Ltd, China). The 12-μm slices of
brain tissue were sectioned using a Leica CM3050 S
cryostat. Apoptosis was detected using a TUNEL kit
(KeyGEN BioTECH, China) following the manufac-
turer’s protocol. The number of TUNEL-positive cells
was counted from four randomly selected fields in each
group, and the counts were expressed as a percentage
of the total number of cells.
Double stainings for TLR2 and NSE, GFAP or Iba1
were performed to evaluate their colocalization by
using the following antibodies: goat anti-TLR2 (1:50,
Santa Cruz, sc-16237) together with rabbit anti-NSE
(1:100, Abcam, ab53025) or mouse anti-GFAP (1:100,
Abcam, ab10062) or rabbit anti-Iba1 (1:50, Santa Cruz,
sc-32725) overnight at 4 °C. The primary antibodies
were visualized using Alexa Fluor 488-conjugated
chicken anti-rabbit (anti-mouse) IgG (1:100, Life Tech-
nologies) together with Alexa Fluor 594-conjugated
donkey anti-goat IgG (1:100, Jackson), and 4’,6-diami-
dino-2-phenylindole (DAPI, 1:100, Yeasen) was used to
stain the nucleus. The images were captured using a
Nikon laser confocal microscope (Nikon, Japan).
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Apoptosis assay
Apoptosis of PC12 cells in the control, OGD and OGD+
MSCs groups was detected using an annexin V-FITC/PI
double-staining kit (KeyGen BioTECH) according to the
manufacturer’s recommendations. Briefly, after treatment,
the cells in the three groups were washed twice with PBS
buffer and then incubated with 5 μl of FITC-conjugated
annexin V and 5 μl of PI in 500 μl of binding buffer for
5 min at room temperature. Apoptotic changes in PC12
cells with different treatments were observed under an
inverted fluorescence microscope (Nikon, Japan) and
photographed using a digital camera.
Statistical analyses
The data are expressed as the means ± SEM. Significant
differences between the groups were determined via one-
way repeated-measures analyses of variance (ANOVAs)
followed by Duncan’s multiple range tests. All statistical
analyses were performed using GraphPad Prism 5.0 soft-
ware (GraphPad Software, Inc., USA). P<0.05 was consid-
ered to be significant.
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